Overcoming Proteasome Inhibitor-Refractory Multiple Myeloma With Elotuzumab, Bortezomib, Nelfinavir, and Dexamethasone.
Erath, Alexandra
Overcoming Proteasome Inhibitor-Refractory Multiple Myeloma With Elotuzumab, Bortezomib, Nelfinavir, and Dexamethasone. [electronic resource] - World journal of oncology Feb 2020 - 33-36 p. digital
Publication Type: Case Reports; Journal Article
1920-454X
10.14740/wjon1241 doi
Overcoming Proteasome Inhibitor-Refractory Multiple Myeloma With Elotuzumab, Bortezomib, Nelfinavir, and Dexamethasone. [electronic resource] - World journal of oncology Feb 2020 - 33-36 p. digital
Publication Type: Case Reports; Journal Article
1920-454X
10.14740/wjon1241 doi